Haleon plc (Haleon) operates as a global leader in consumer health, with brands trusted by various consumers globally. Haleon’s product portfolio spans five major categories, such as oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and other. Its long-standing brands, such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.
The...
Haleon plc (Haleon) operates as a global leader in consumer health, with brands trusted by various consumers globally. Haleon’s product portfolio spans five major categories, such as oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and other. Its long-standing brands, such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.
The company invests in a suite of proprietary assets to generate deep human understanding to support brand innovation and enhance its engagement with Health Professionals to help educate consumers. This includes dedicated shopper research centres, consumer knowledge and social listening, all designed to generate and test new insights and identify consumer needs. Through innovation, the company addresses unmet consumer needs and emerging trends, target products towards a particular demographic and improve delivery mechanisms for existing products.
The company’s investment in Advertising and Promotion (A&P) activities, such as paid media, in-store promotions, TV and print, coupled with a strong focus on digital capabilities has enhanced its brand equity with brands consumers trust, thereby empowering more people to self-care. The company has direct and trusted relationships with more than three million Health Professionals, together with the largest network of pharmacies in the world who recognize the strength and efficacy of its products, which they recommend to consumers, bringing new users to its brands and categories.
The company is organized into business units based on geographical areas and has three segments: North America; Europe, Middle East, Africa and Latin America (EMEA and LatAm); and Asia Pacific (APAC). The company’s nine large-scale, multinational Power Brands are complemented by a strong set of 23 Local Growth Brands, which are iconic in their own markets.
Oral Health
As one of the world’s largest providers of oral health, the company’s science-based products are designed to fight against everyday oral health problems.
Vitamins, Minerals and Supplements (VMS)
The company’s extensive range of vitamins, minerals and supplements is designed to improve people’s everyday health and wellness.
Pain Relief
The company has a portfolio of leading brands to relieve pain and reduce inflammation, helping people manage their everyday pain.
Respiratory Health
The company’s respiratory health brands offer product solutions for a broad range of respiratory issues, including cold and flu, nasal congestion, coughs and allergies.
Digestive Health and Other
The company’s digestive health brands have a strong heritage in treating heartburn and gastric discomfort. The company’s product offerings in this category also include skin health and smokers’ health.
Strategy
The company’s strategy seeks to deliver sustainable above-market growth and attractive returns, while running a responsible business, which is integral to all it does. The key elements of the company’s strategy are to increase household penetration; capitalize on new and emerging opportunities; run a responsible business; maximize significant growth opportunities across its categories by applying its proven approach to penetration-led growth; increase growth of its brands across channels, routes-to market and geographies; expand its portfolio through new and emerging consumer trends and by pursuing Rx-to-OTC switches; focus on driving efficiency, effectiveness, and agility to make every investment count; make everyday health more inclusive; protect the environment and address social sustainability barriers to everyday health; embed strong governance and ethical business behaviors; continue to drive penetration with new audiences by further enhancing its brands’ visibility and relevance to their unmet needs; continue to build an innovation pipeline focusing on specialist solutions; and maximize relationships with health professionals to increase consumer reach through trusted experts.
History
The company was incorporated in 2021. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in 2022.